Aminoterminal propeptide of type III procollagen: A marker of hepatic fibrosis after bile duct obstruction in the monkey

Hepato-Gastroenterology

Volumn 43, Issue 7, 1996, Pages 121-126

  Ruf, Günther ^a   Mappes, Hans J ^a   Koch, Herbert ^a   Baumgartner, Ulrich ^a   Hagmann, Wolgang ^b   Farthmann, Eduard H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Aminoterminal propeptide of type III procollagen leucotrienes; Bile duct obstraction sequential; Hepatic fibrosis; Segmental

Indexed keywords

DEXAMETHASONE; LEUKOTRIENE C4; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; INTRAHEPATIC BILE DUCT; LIGATION; LIVER BIOPSY; LIVER FIBROSIS; MONKEY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANIMALS; BIOLOGICAL MARKERS; CHOLESTASIS; COLLAGEN; DEXAMETHASONE; ENDOTOXINS; GLUCOCORTICOIDS; LEUKOTRIENE C4; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MACACA FASCICULARIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; RADIOIMMUNOASSAY;

EID: 0029864371     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hahn Wick G, Pencer D, Timpl R: Distribution of basement proteins in normal and fibrotic human liver; collagen type IV, laminin and fibronectin Gut 1980; 21:63-71.
2. Rojkind M, Martinez-Palomo A: Increase in type I and type III collagens in human alcoholic liver cirrhosis Proc Natl Acad Sci USA 1976; 73: 539-643.
3. Davis BH, Madri JA: Type I and type III procollagen peptides during hepatic fibrogenesis Am J Pathol 1987; 126:137-147.
4. Martinez-Hernandez A: The hepatic extracellular matrix, I Electronimmunohistochemical studies in normal rat liver Lab Invest 1984; 51: 57-74.
5. Rojkind M, Giambrone MA, Biembica L: Collagen types in normal and cirrhotic livers Gastroenterology 1979; 76:710-719.
6. McCullough AJ, Stassen WN, Wiesner RH, Czajy AJ: Serial determination of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis J Lab Clin Med 1987; 109:55-61.
7. Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R: Radioimmunassay for type III procollagen peptide and its application to human liver disease Eur J Clin Invest 1979; 9:451-459.
8. Frei A, Zimmermann A, Weigand K: The N terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease Hepatology 1984; 4:830-834.
9. Niemela O, Ristelli L, Sotaniemi EA, Risteli J: Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease Gastroenterology 1983; 85: 254-259.
10. Surrenti C, Casini A, Milani S, Ambu S, Ceccatelli P, D Agata A: Is determination of serum N-terminal procollagen type III peptide a marker of hepatic fibrosis? Digest Dis Sci 1987; 32:705-709.
11. Weigand K, Zangg PY, Frei A, Zimmermann A: Long-term follow up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease Hepatology 1984; 4: 835-838.
12. Ruf G, Mappes HJ, Lausen M, Schwffel U, Koch H, Farthmann EH: Untersuchungen zur Pathomorphologie der Leber nach unilateralem Hepatikusverschlu Ω mit laborchemischer Verlaufskontrolle Helv chir Acta 1989; 56:169-173.
13. Ruf G, Mappes HJ, Baumgartner U, Hagmann W, Koch H, Keppler D, Farthmann EH: Induction of secondary biliary cirrhosis after segmental bile duct obstruction with leukotriene C4 in press
14. Gallorini A, Plebani M, Pontisso P, Chemello L, Masiero M, Mantovani G, Alberti: A Serum markers of hepatic fibrogenesis in chronic hepatitis type C with alfa-2A interferon Liver 1994; 14:257-264.
15. Trinchet JC, Kartmann DJ, Pateron D, Laarif M, Callard P, Ville G, Beaugrand M: Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatits J Hepatol 1991; 12: 139-144.
16. Murawaki Y, Ikuta Y, Koda M, Kawasaki H: Serum type III procollagen peptide, type IV collagen /s domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronoc viral liver disease: relationship to liver histology Hepatology 1994; 20:780-787.
17. Hayasaka A, Koch J, Schuppan D, Maddrey WC, Hahn EG: The serum concentrations of the aminotzerminal propeptide of procollagen type III and the hepatic content of mRNA for the 1 chain of procollagen type III in carbon tetrachloride-incluced liver fibrogenesis J hepatology 1991; 13:328-338.
18. Schuppan D: Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis J Hepatol 1991; 13:517-525.
19. Rojkind M, Rojkind MH, Cordero-Hernandez J: In vivo collagen synthesis and deposition in fibrotic and regenerating rat livers Collagen Rel Res 1983; 3:335-337.
20. Teare JP, Sherman D, Greefield SM, Simpson J, Bray G, Catteral AP, Murray-Lyon IM, Peters TJ, Williams R, Thompson RPH: Comparison of serumprocollagen III peptide concentrations and PGA index for assesment of hepatic fibrosis Lancet 1993; 342:895-898.
21. Murata K, Kudo M, Onuma F, Motoyama T: Changes of collagen types at various stages of human liver cirrhosis Hepatogastroenterol 1984; 31:158-161.
22. Meghji S, Sandy JR, Harvey W, Henderson B, Ali N: Stimulation of bone collagen and non-collagenous protein synthesis by products of 5-and 12-lipoxygenase: determination by use of a simple quantitative assay Bone & Mineral 1992; 18:119-132.
23. Ren W, Dziak R: Effects of leukotrienes on osteoblastic cell proliferation Calcif Tissue Int 1991; 49: 197-201.
24. Phan SH, McGarry BM, Lwffler KM, Kunkel SL: Binding of leukotriene C4 to rat lung fbroblasts and stimulation of collagen synthesis in vitro Biochemistry 1988; 27:2846-2853.
25. Keppler D: Leukotrienes: biosynthesis, transport, inactivation, and analysis Rev Physiol Biochem Pharmacol 1992; 121: 2-30.
26. Torres-Salinas M, Pares A, Caballeria J, Jiminez W, Heredia D, Bruguera M, Rodes J: Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis Gastroenterology 1986; 90:1241-1246.
27. Schuppan D, Dumont J, Kim KY, Hennings G, Hahn EG: Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis J Hepatol 1986; 3: 27-37.
28. Maruyama K, Okazaki T, Kobayashi T: Measurement of serum type III procollagen aminopeptide as a parameter of hepatic fbrosis Acta Hepatol Jpn 1984; 25: 24-32.
29. Tanaka Y, Minato Y, Hasamura Y, Takeuchi J: Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholoc patients Digest Dis Sci 1986; 31: 712-717.